KODIAK SCIENCES INC (KOD)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for KOD
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| KOD | Director; Board Member | 68 | ["senior advisor of Baker Bros. Advisors LP","Executive Vice President and Chief Drug Development Officer of Incyte Corporation","Senior Vice President of Drug Development at Incyte","Vice President, Biologic Therapies at Celgene Corporation","various executive positions with DuPont Pharmaceuticals","Assistant Professor of Medicine at UCLA School of Medicine"] | ["Nominating and Governance","Nominating and Corporate Governance"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| MDGL | Class III Director | 68 | ["Executive Vice President and Chief Drug Development Officer at Incyte from January 2009 until April 2016","Senior Vice President of Drug Development at Incyte from August 2003 to January 2009","Vice President, Biologic Therapies, at Celgene from 2002 to 2003","Various executive positions with DuPont Pharmaceuticals Company from 1997 to 2001","Increasing responsibility in clinical research and regulatory affairs at Novartis AG from 1991 to 1997","Part-time Senior Advisor for BBA from December 2016 to May 2019","Board Certified in Internal Medicine and Gastroenterology"] | ["Audit","Science and Technology","Nominating and Governance","Science and Technology Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Levy is board certified in Internal Medicine and Gastroenterology and received his A.B. in Biology from Brown University, his M.D. from the University of Pennsylvania School of Medicine and completed his training in Internal Medicine at the Hospital of the University of Pennsylvania and a fellowship in Gastroenterology and Hepatology at UCLA. Relevant Expertise We believe Dr. Levy s significant management experience in the pharmaceutical industry and medical training qualify him to serve on our board of directors. Other Public Company Boards Kiniksa Pharmaceuticals, Ltd. Madrigal Pharmaceuticals Inc. ProTara Therapeutics Inc.